QEY · Class II · 21 CFR 870.5150

FDA Product Code QEY: Mechanical Thrombolysis Catheter

Mechanical thrombolysis augments aspiration with active clot disruption. FDA product code QEY covers mechanical thrombolysis catheters used in peripheral and coronary vessels.

These devices use high-velocity fluid jets, rotating elements, or acoustic energy to mechanically fragment thrombus while simultaneously aspirating the debris, enabling more complete clot removal than aspiration alone in acute arterial and venous occlusions.

QEY devices are Class II medical devices, regulated under 21 CFR 870.5150 and reviewed by the FDA Cardiovascular panel.

Leading manufacturers include Thrombolex, Inc., AngioDynamics, Inc. and Btg International, Inc..

71
Total
71
Cleared
79d
Avg days
1995
Since
Growing category - 3 submissions in the last 2 years vs 2 in the prior period
Review times increasing: avg 148d recently vs 76d historically

FDA 510(k) Cleared Mechanical Thrombolysis Catheter Devices (Product Code QEY)

71 devices
1–24 of 71
Cleared Feb 17, 2026
Versus™ Catheter (VS110-9NB)
K260149
Liquet Medical, Inc.
Cardiovascular · 28d
Cleared Jan 20, 2026
VariFuse Adjustable Infusion Catheter
K251318
Argon Medical Devices, Inc.
Cardiovascular · 266d
Cleared Nov 25, 2024
Versus™ Catheter (VS110-8B)
K241851
Liquet Medical, Inc.
Cardiovascular · 151d
Cleared Jul 03, 2023
BASHIR™ .035 Endovascular Catheter, BASHIR™ S-B .035 Endovascular Catheter
K231653
Thrombolex, Inc.
Cardiovascular · 27d
Cleared Apr 20, 2023
BASHIR Endovascular Catheter Ref. No. 7201, BASHIR S-B Endovascular Catheter, Ref. No. 7101
K222095
Thrombolex, Inc.
Cardiovascular · 276d
Cleared Apr 20, 2022
EKOS+ Endovascular Device
K220866
Boston Scientific
Cardiovascular · 26d
Cleared Dec 14, 2021
EkoSonic Endovascular Device, EKOS+ Endovascular Device
K213422
Boston Scientific Corporation
Cardiovascular · 55d
Cleared Nov 19, 2021
EkoSonic Endovascular Device
K211080
Boston Scientific
Cardiovascular · 221d
Cleared Jun 10, 2021
BASHIR Endovascular Catheter (Ref. 7201), BASHIR Plus 10 Endovascular Catheter (Ref. 7210), BASHIR Plus 20 Endovascular Catheter (Ref. 7220), BASHIR Plus 30 Endovascular Catheter (Ref. 7230), BASHIR Plus 40 Endovascular Catheter (Ref. 7240)
K211061
Thrombolex, Inc.
Cardiovascular · 62d
Cleared Sep 15, 2020
UNIFUSE Infusion System with Cooper Wire
K202347
AngioDynamics, Inc.
Cardiovascular · 28d
Cleared Aug 17, 2020
EKOS PE Endovascular Device with Control System 4.0 (CS4.0)
K200648
Ekos Corporation
Cardiovascular · 158d
Cleared Jun 01, 2020
UNI*FUSE Infusion System with Cooper Wire
K192864
AngioDynamics, Inc.
Cardiovascular · 238d
Cleared Dec 17, 2019
Bashir Plus Endovascular Catheter
K193071
Thrombolex, Inc.
Cardiovascular · 43d
Cleared Oct 18, 2019
Bashir S-B Endovascular Catheter, Ref. No. 7101
K192598
Thrombolex, Inc.
Cardiovascular · 28d
Cleared Aug 23, 2019
EkoSonic Endovascular Device
K191119
Btg International, Inc.
Cardiovascular · 119d
Cleared Apr 05, 2019
EkoSonic Endovascular Device with Control Unit 4.0
K183361
Btg International, Inc.
Cardiovascular · 122d
Cleared Feb 25, 2019
Bashir Endovascular Catheter Model 7201, Bashir N-X Endovascular Catheter, Mode 7200
K183290
Thrombolex, Inc.
Cardiovascular · 91d
Cleared Nov 26, 2018
EkoSonic Endovascular System
K182324
Btg International, Inc.
Cardiovascular · 91d
Cleared May 30, 2017
Pulse* Spray Infusion System, Uni*Fuse Infusion System
K163356
AngioDynamics, Inc.
Cardiovascular · 181d
Cleared Feb 21, 2017
SpeedLyser Infusion Catheter Kit
K170258
AngioDynamics, Inc.
Cardiovascular · 25d
Cleared Aug 14, 1997
Cordis Endeavor Infusion Catheter
K972110
Cordis Corp.
Cardiovascular · 70d
Cleared May 28, 1997
Cordis Endeavor Infusion Catheter
K970842
Cordis Corp.
Cardiovascular · 82d

About Product Code QEY - Regulatory Context

510(k) Submission Activity

71 total 510(k) submissions under product code QEY since 1995, with 71 receiving FDA clearance (average review time: 79 days).

Submission volume has increased in recent years - 3 submissions in the last 24 months compared to 2 in the prior period - suggesting growing market activity in this device classification.

FDA 510(k) Review Time - QEY Product Code

Recent submissions under QEY have taken an average of 148 days to reach a decision - up from 76 days historically. Manufacturers should account for longer review timelines in current project planning.

QEY devices are reviewed by the Cardiovascular panel. Browse all Cardiovascular devices →